Navigation Links
World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

Driven by the human genome project, and research in the area of AIDS, geriatric diseases, neurosciences, and drug development (antiviral, antibacterial, antifungal, and genetic therapeutics), world market for biotechnology reagents is projected to reach $32.5 billion by 2012. The shift towards proteomics from genomics in the post-genome-project research period is forecast to benefit protein related product markets in the upcoming years.

San Jose, California (PRWEB) November 13, 2008 -- Reagents used in biotechnology are complex chemical compounds used in a range of biotech related areas including biochemistry, cell biology, molecular biology, immunology, protein chemistry, pharmacology, and biotechnology research. The market is dependent to a large extent on applications of biotechnology instrumentation. With the focus shifting from the gene towards the protein, disciplines such as molecular biology and protein synthesis continue to gain wide attention from the academic and commercial sectors alike. However, highly automated instrumentation is expected to temper the use of reagents. The whole spectrum of biotech, medical, and biological technologies has facilitated researchers to develop highly specialized human biological products with significant therapeutic and commercial potential. Yet, the most significant value provided by these technologies may not be limited to their end products. Greater value will be the insights provided into the disease processes.

As stated by the recent report published by Global Industry Analysts Inc, United States and Europe collectively account for a share of nearly 65% of the global biotechnology reagents market estimated in 2008. Driven by its extensive use in large-scale commercial applications, and in basic research, biotechnology reagents in Asia-Pacific are forecast to grow at the fastest CAGR of 8.75% over the period 2011 through 2015. Immunoassay reagents market represents the largest product market worldwide with revenues forecast to reach US$13.8 billion by 2012. With the present emphasis of research studies focused on determining the activation state of a protein rather than unraveling the gene, which hitherto involved the use of DNA arrays and mRNA profiling, world market for protein synthesis reagents is forecast to grow at a robust CAGR of 10.38% over the period 2011 through 2015. Driven by its increasing use in life sciences applications, liquid chromatography reagents market in the US is expected to reach US$3.4 billion by the year 2015. Biotech and pharmaceutical industries constitute the major consumers of chromatography reagents.

Key players dominating the marketplace include Abbott Diagnostics, Applied Biosystems, Beckman Coulter Inc., Becton Dickinson and Company, Biomerieux SA, Chemicon International Inc., Cortex Biochem Inc., EMD Biosciences Inc., GE Healthcare, Invitrogen Corporation, Ortho-Clinical Diagnostics, PerkinElmer Inc., Promega Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc and Sigma - Aldrich, among others.

The report titled "Biotechnology Reagents: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market dynamics, trends, issues, and competition. The report enumerates recent product launches, innovations, developments, mergers, acquisitions and other strategic industry activities. Product segments analyzed in the study include Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents. Analysis is presented for established and emerging markets including United States, Canada, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, and Latin America.

For more details of this research report, please visit

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
Post Your Comments:
Related Image:
World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
(Date:11/24/2015)... , Nov. 24, 2015 According to two ... in 2005. This is something that many doctors, scientists, and ... One questions remains: with fewer PSA tests being done, will ... Dr. David Samadi, "Despite the efforts ... disease remains the second leading cancer cause of death in ...
(Date:11/23/2015)... -- China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the second quarter and first half ... --> --> Second Quarter ... second quarter of fiscal 2016 increased by 12.7% to ...
(Date:11/23/2015)... -- The royalty-free a greement a ... daclatasvir for 112 low- and m iddle-i ... --> The Medicines Patent Pool (MPP) today ... an agreement with Bristol-Myers Squibb for daclatasvir, a novel direct-acting ... the HCV virus.  The royalty-free licence will enable generic manufacture ...
(Date:11/23/2015)... Inc. (NYSE: CRY ), a leading medical device and ... today that it will participate in the upcoming 27 th ... 2015 at The New York Palace Hotel in ... President and Chief Executive Officer. --> Pat ... A live webcast of the Company,s presentation is scheduled ...
Breaking Biology Technology:
(Date:10/29/2015)... YORK , Oct. 29, 2015 ... technology, announced a partnership with 2XU, a global ... to deliver a smart hat with advanced bio-sensing ... and other athletes to monitor key biometrics to ... the strategic partnership, the two companies will bring together ...
(Date:10/27/2015)... BERLIN, Germany , October 27, 2015 ... 2015. SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically ... SMI,s Eye Tracking Glasses , so that ... Suite BeGaze. --> Munich, Germany ... technology (ASGM) automatically maps data from mobile eye tracking ...
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
Breaking Biology News(10 mins):